Kiora Pharmaceuticals Inc

Research Kiora Pharmaceuticals Inc (KPRX) on Bullrun: market cap USD 11.57M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerKPRX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 11.57M
• Financial periodFY2025
• Revenue growth-100.0%
• Net income-USD 10.84K
• Free cash flow-USD 10.07M

Valuation Snapshot

latest market cap is USD 11.57M.

About Kiora Pharmaceuticals Inc

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease.

Frequently asked questions

What is Kiora Pharmaceuticals Inc's market cap?

Kiora Pharmaceuticals Inc's market capitalization is USD 11.57M.

What does Kiora Pharmaceuticals Inc do?

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.